Use of quantitative polymerase chain reaction to study cellular retinoic acid-binding protein-II mRNA expression in human skin.
Zhou
L
L
R. W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey 08869, USA.
Otulakowski
G
G
Lau
C Y
CY
D000818:Animals; D001483:Base Sequence; D001706:Biopsy; D017931:DNA Primers; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D007202:Indicators and Reagents; D051379:Mice; D016133:Polymerase Chain Reaction / Q000379:methods*; D011565:Psoriasis / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis*; D018168:Receptors, Retinoic Acid / Q000096:biosynthesis*; D012016:Reference Values; D012867:Skin / Q000166:cytology / Q000378:metabolism* / Q000473:pathology; D016038:Skin Transplantation; D014158:Transcription, Genetic; D014183:Transplantation, Heterologous
D017931:DNA Primers; D007202:Indicators and Reagents; D012333:RNA, Messenger; D018168:Receptors, Retinoic Acid; C082927:retinoic acid binding protein I, cellular; C082928:retinoic acid binding protein II, cellular